Caregen케어젠
214370 · KOSDAQ · ₩214370 · 케어젠
₩33,950▼ ₩400 (1.16%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩73B | ₩83B | ₩79B | ₩69B | ₩59B |
| Cost of sales | ₩21B | ₩27B | ₩21B | ₩17B | ₩14B |
| Gross profit | ₩52B | ₩55B | ₩58B | ₩52B | ₩46B |
| Operating income | ₩20B | ₩34B | ₩40B | ₩34B | ₩28B |
| Net income | ₩20B | ₩32B | ₩40B | ₩27B | ₩25B |
| Net income to shareholders | ₩20B | ₩32B | ₩40B | ₩27B | ₩25B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩231B | ₩241B | ₩247B | ₩234B | ₩227B |
| Current assets | ₩83B | ₩96B | ₩166B | ₩159B | ₩149B |
| Cash and equivalents | ₩8.9B | ₩5.1B | ₩32B | ₩5.2B | ₩22B |
| Total liabilities | ₩19B | ₩18B | ₩20B | ₩18B | ₩17B |
| Current liabilities | ₩8.4B | ₩8.1B | ₩11B | ₩10B | ₩9.8B |
| Borrowings | ₩2.8B | ₩2.4B | ₩3.4B | ₩3.5B | ₩3B |
| Total equity | ₩212B | ₩223B | ₩227B | ₩216B | ₩210B |
| Shareholders' equity | ₩212B | ₩223B | ₩227B | ₩216B | ₩210B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩19B | ₩13B | ₩29B | −₩28B | ₩52B |
| Capital spending | ₩3.9B | ₩66B | ₩8.2B | ₩1.5B | ₩3.9B |
| Free cash flow | ₩15B | −₩52B | ₩20B | −₩29B | ₩48B |
| Dividends paid | ₩31B | ₩31B | ₩28B | ₩25B | ₩21B |
Consolidated where available. Amounts in won.
Also known as: Caregen / 케어젠 / 214370 / KRX:214370
Source: KRX statistical information